Cidara Therapeutics, Inc. — Investor Relations & Filings
Cidara Therapeutics, Inc. is a biotechnology company that develops targeted immunotherapies and novel anti-infectives for patients with serious diseases. The company utilizes its proprietary Cloudbreak® platform to create drug-Fc conjugates (DFCs). These DFCs are engineered as 'single molecule cocktails' by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach is designed to directly inhibit disease targets, such as fungal or viral pathogens, while simultaneously engaging the patient's immune system. The company's focus is on developing therapies for the treatment and prevention of life-threatening infections and other serious conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English | |
| Regulatory Filings 2026 | 2026-01-12 | English | |
| Regulatory Filings 2026 | 2026-01-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 30910938 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30910864 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30910905 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30910876 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 12788824 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788825 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788826 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788827 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788828 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788829 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 12788830 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12788831 | Major Shareholding Notification 2026 | 2026-01-09 | English | ||
| 12788832 | FORM 4 | 2026-01-08 | English | ||
| 12788833 | FORM 4 | 2026-01-08 | English | ||
| 12788834 | FORM 4 | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cidara Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31535/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31535 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31535 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31535 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31535}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cidara Therapeutics, Inc. (id: 31535)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.